Kids Medical Systems share price

BSE: 540812Healthcare Services

Kids Medical Systems Limited · Face value ₹10 · Listed Dec 2017

Trading suspended since 21 Nov 2024

Last traded ₹7.98 on 3 Feb 2020

Latest announcements

Routine notices left out.

Share price history

Daily closes since Dec 2017, adjusted for splits and bonuses

Daily close, ₹ per share

Results for the half year to Sep 2024

Standalone: the listed company alone, without its subsidiaries. ₹ crore.

Revenue
₹0.00 Cr
Operating profit
−₹0.01 Cr
Net profit
−₹0.01 Cr
Earnings per share
−₹0.01

From revenue to net profit, ₹ crore

  1. Revenue0.0
  2. Employee costs0.0
  3. Other expenses0.0
  4. Operating profit0.0
  5. Depreciation0.0
  6. Other income0.0
  7. Finance costs0.0
  8. Profit before tax0.0
  9. Tax0.0
  10. Net profit0.0

Kids Medical Systems results by half year

Standalone: the listed company alone, without its subsidiaries. Latest half year to Sep 2024. Results for the half year to Mar 2025 were due by 30 May 2025, 60 days after it ends. Every company's dates are on the results calendar.

Revenue and net profit by half year, ₹ crore

  • Revenue
  • Net profit
  • Loss
00.0Mar 220Sep 2200.0Mar 2300.0Sep 2300.0Mar 2400.0Sep 24
Peak revenue ₹0.00 Cr, half year to Mar 2022A loss in 5 of the 5 half years with results on record

Operating and net margin by half year, per cent

  • Operating margin
  • Net margin
₹ croreMar 2020Sep 2020Mar 2021Sep 2021worked outMar 2022Sep 2022worked outMar 2023Sep 2023Mar 2024Sep 2024
Revenue from operations0.120.030.000.000.000.000.000.000.000.00
–0.00–––––0.04–0.01
Materials and goods bought0.000.000.000.000.000.000.000.000.000.00
Employee costs–0.00–––––0.00–0.00
Other expenses–0.00–––––0.04–0.01
Operating profit before depreciation–0.03–––––−0.04–−0.01
Operating margin–100.0%––––––––
Depreciation and amortisation–0.00–––––0.00–0.00
Other income0.000.000.000.000.000.000.000.000.000.00
Finance costs0.000.000.000.000.000.000.000.000.000.00
Profit before tax0.050.03−0.01–−0.02–−0.01−0.03−0.03−0.01
Tax0.000.000.000.000.000.000.000.000.000.00
Tax rate0.0%0.0%––––––––
Net profit0.050.03−0.01–−0.02–−0.01−0.03−0.03−0.01
Net margin38.2%102.5%––––––––
Earnings per share₹0.07₹0.04−₹0.02–−₹0.02––−₹0.04−₹0.04−₹0.01
Earnings per share in rupees, restated for later splits and bonuses.

7 years at a glance

Standalone: the listed company alone, without its subsidiaries. ₹ crore, years to March.

Revenue, net profit and borrowings, ₹ crore

  • Revenue
  • Net profit
  • Borrowings
  • Loss
0.5−0.3Mar 180.3−0.30.4Mar 190.30.10.3Mar 200.00.00.3Mar 2100.00.3Mar 2200.00.3Mar 230−0.10.3Mar 24
Peak revenue ₹0.51 Cr, year to Mar 2018; lowest ₹0.00 Cr, year to Mar 2022A loss in 5 of the 7 years shown

Operating and net margin, per cent

  • Operating margin
  • Net margin
51.3%−99.4%−43.9%51.3%45.8%−55.6%−99.4%51.2%50.2%Mar 18Mar 19Mar 20Mar 21Mar 22Mar 23Mar 24

Results for the year to Mar 2024

Standalone: the listed company alone, without its subsidiaries. ₹ crore.

From revenue to net profit

  1. Revenue0.0
  2. Employee costs0.0
  3. Other expenses−0.1
  4. Operating profit−0.1
  5. Depreciation0.0
  6. Other income0.0
  7. Finance costs0.0
  8. Profit before tax−0.1
  9. Tax0.0
  10. Net profit−0.1

What the company owns

  • Plant, investments and other assets₹7 Cr
  • Cash and bank₹0 Cr
  • Receivables₹0 Cr

What pays for it: net worth and liabilities

  • Net worth₹7 Cr
  • Other liabilities₹0 Cr
  • Borrowings₹0 Cr

Profit and loss

Standalone, ₹ crore, years to March. The last column is the twelve months to Sep 2024, the latest two half years added.

₹ croreMar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Sep 2024Twelve months
Revenue from operations0.510.340.260.030.000.000.000.00
0.74–0.120.020.020.010.06–
Materials and goods bought0.080.220.000.000.000.000.000.00
Employee costs0.33–0.040.000.000.000.00–
Other expenses0.33–0.090.020.020.010.06–
Operating profit before depreciation−0.23–0.130.01−0.02−0.01−0.06–
Operating margin−43.9%–51.3%45.8%––––
Materials, % of revenue15.1%–0.2%0.0%––––
Employee costs, % of revenue63.7%–15.2%0.0%––––
Other expenses, % of revenue65.2%–33.3%54.2%––––
Depreciation and amortisation0.04–0.000.000.000.000.00–
Operating profit after depreciation−0.27–0.130.01−0.02−0.01−0.06–
Other income0.040.000.000.000.000.000.010.00
Finance costs0.050.010.000.000.000.000.000.00
Profit before tax−0.29−0.340.130.01−0.02−0.01−0.06−0.04
Tax–0.000.000.000.000.000.000.00
Net profit−0.29−0.340.130.01−0.02−0.01−0.06−0.04
Net margin−55.6%−99.4%51.2%50.2%––––
Operating expenses, operating profit before depreciation and operating profit after depreciation are left blank for the year to Mar 2019: the statement does not state its depreciation, which operating profit is worked out from, so operating profit is not given.

Balance sheet

Standalone, ₹ crore, at 31 March. The last column is the half year to Sep 2024, after the latest full year: the balance sheet at its end.

₹ croreMar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Sep 2024Half year
7.247.377.387.377.367.317.30
Share capital7.097.097.097.097.097.097.09
Reserves0.150.280.290.280.270.220.20
Borrowings0.370.250.250.260.260.260.26
0.590.490.510.530.530.560.56
Liabilities due after a year0.000.000.000.000.000.000.00
Total assets7.837.867.897.907.907.877.86
0.400.420.420.420.340.340.34
7.427.457.477.487.567.537.52
Net debt0.180.070.030.040.040.030.03
Borrowings are counted again inside the liabilities due within a year and after a year. Plant in use and plant being built are given for full years only. No balance sheet is on record for the year to Mar 2018, so its lines and the ratios worked from it are blank there.

Cash flow

Standalone, ₹ crore, years to March. The last column is the half year to Sep 2024, after the latest full year: the cash flow over its six months.

₹ croreMar 2020Mar 2021Mar 2022Mar 2023Mar 2024Sep 2024Half year
0.130.030.000.00−0.07−0.01
0.130.030.000.00−0.06−0.01
0.000.020.020.010.000.00
Receivables0.000.000.000.000.000.00
Payables0.010.000.000.010.020.00
Other working capital−0.010.020.020.00−0.030.00
Interest paid0.000.000.000.00−0.010.00
Capital spending0.000.000.000.000.000.00
Free cash flow0.120.030.000.00−0.07−0.01
−0.010.000.000.000.080.01
−0.120.000.000.000.000.00
Dividends paid0.000.000.000.000.000.00
Shares issued0.000.000.000.000.000.00
Net change in cash−0.010.030.000.000.010.00
Capital spending is part of cash from investing, and dividends paid, shares bought back and shares issued are part of cash from financing. Each is shown as an amount on a line of its own, and the section's other items are in its total only. No cash flow statement is on record for the years to Mar 2018 and Mar 2019.

Per share

Standalone, ₹ per share, years to March.

₹ per shareMar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024
Earnings per share₹0.00₹0.18₹0.02−₹0.02–−₹0.08
Diluted earnings per share₹0.00₹0.18₹0.02−₹0.02–−₹0.08
Book value per share–₹10.39₹10.41₹10.39–₹10.30
Earnings per share is left blank for the year to Mar 2023: the earnings per share is stated as 0 while the period's profit or loss comes to at least half a paisa a share, so the 0 stands in for a figure the filing does not give.

Ratios

Standalone, years to March.

RatioMar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024
Revenue growth−33.4%−25.1%−89.2%−100.0%––
Operating profit growth––−90.3%–––
Net profit growth––−89.4%–––
Earnings per share growth––−88.9%–––
−4.7%1.8%0.2%–––
–6.5 pts−1.6 pts–––
From the net margin–7.1 pts0.0 pts–––
From asset turnover–−0.6 pts−1.6 pts–––
From borrowing–0.0 pts0.0 pts–––
Return on capital employed–1.7%0.2%−0.2%−0.1%−0.8%
Cash conversion–96.7%223.7%–––
Interest cover–77.363.5–––
Debt to equity0.050.030.030.030.030.04
Receivable days2383172,932–––
Inventory days00––––
Payable days–56,429––––
Cash conversion cycle, days–−56,112––––
Working capital days7,49010,00592,263–––
Asset turnover0.040.030.000.000.000.00
Assets per rupee of net worth1.081.071.071.071.071.07
Sales per rupee of plant1.841.370.150.000.000.00
Interest cover is left blank for the years to Mar 2018 and Mar 2024: operating profit after depreciation is a loss, and a loss covers no interest bill. No balance sheet is on record for the year to Mar 2018, so its lines and the ratios worked from it are blank there.

Growth and returns over 3, 5 and 10 years

Standalone: the listed company alone, without its subsidiaries. Each window ends with the year to Mar 2024.

Return on assets, latest year
−0.7%
Measure5 years3 years
Return on capital employed, average0.2%−0.4%
Asset turnover, average0.010.00
Debt to equity, average0.030.04

Where the cash came from and went

Standalone: the listed company alone, without its subsidiaries. ₹ crore, added up over each window, which ends with the year to Mar 2024.

₹ crore5 years3 yearsLatest year
Cash from operations0.09−0.07−0.07
Cash from investing0.070.080.08
Cash from financing−0.120.000.00
Capital spending0.000.000.00
Dividends paid0.000.000.00
Shares issued for cash0.000.000.00
Borrowings raised0.000.000.00
Borrowings repaid0.120.000.00

Accounting checks

Standalone, years to March. Published tests of whether reported profit is backed by cash and the balance sheet.

CheckMar 2020Mar 2021Mar 2022Mar 2023Mar 2024
Receivables growth less revenue growthOur threshold 0 percentage points24.7189.18100.36––
Other current assets growth less revenue growthOur threshold 5 per cent of revenue11.57−17.69–––
Effective tax ratePublished threshold 17.16 per cent0.000.00–––
Tax charged less tax paid, % of profitOur threshold 10 percentage points0.000.00–––
A threshold marked as ours has no published figure; it is the line we read the check against.

Business segments

In the year to Mar 2024 the company reports one business segment, Pediatrics Services, which carries all its revenue.

Kids Medical Systems share price by year

Each calendar year to 2020.

YearClose at year endChangeHighest closeLowest close
20207.98−5.0%7.987.98
20198.40−30.0%11.408.40
201812.00−68.0%56.2011.65
201737.45–37.4534.10
₹ per share, adjusted for splits and bonuses since. Change is on the close at the end of the year before. 2020 is from its first session, 3 Feb 2020. 2019 is from its first session, 13 Nov 2019. 2017 is from its first session, 22 Dec 2017. The close is the year's last trade for 2020 (3 Feb 2020), 2019 (11 Dec 2019) and 2018 (30 Nov 2018).

Recent sessions

The 10 trading days to 3 Feb 2020, as traded on BSE.

DateOpenHighLowCloseAverage priceVolume
3 Feb 20207.987.987.987.987.984,000
11 Dec 20198.408.408.408.408.404,000
10 Dec 20198.848.848.848.848.844,000
5 Dec 20199.309.309.309.309.304,000
29 Nov 20199.789.789.789.789.784,000
20 Nov 201910.2910.2910.2910.2910.294,000
19 Nov 201910.8310.8310.8310.8310.834,000
13 Nov 201911.4011.4011.4011.4011.404,000
30 Nov 201812.0012.0012.0012.0012.001,00,000
26 Sep 201812.2512.2511.6511.6512.231,48,000
Prices in ₹ per share as traded, not adjusted.

Company details

BSE code
540812
ISIN
INE457Y01014
Industry
Healthcare Services
CIN
L85110GJ2013PLC075191
Corporate identity number, the registrar of companies' code for it
Incorporated
2013
Registered office
3rd Floor, Chinubhai House, 7/B Amrutbaug Colony, Opp. Sardar Patel stadium, Near Hindu Colony Navrangpura, Navjivan, Ahmedabad 380014, Gujarat
Share registrar
Purva Sharegistry (India) Pvt. Ltd
Keeps the register of shareholders and handles transfers and dividend payments